Frank Reed

Hallmark Health Care Solutions assembles a powerhouse advisory board of former health system CEOs to address critical workforce challenges and drive innovation in healthcare labor management.

A massive influx of capital and a new advanced pharmaceutical manufacturing center are positioning Virginia as a key player in the reshoring of biopharmaceutical production and the development of a highly-skilled workforce.

A domestic generic drug maker's plea for policy changes highlights the fragility of the U.S. pharmaceutical supply chain, revealing reliance on foreign sources and a complex web of pricing challenges. Can reshoring efforts overcome economic realities?

Clinical trial supply firm Myonex prepares for a new chapter with Greg Lavin stepping into the CEO role. The company's strategic acquisitions and focus on integrated solutions position it for success in an evolving market.

USA Pickleball partners with Epicore Biosystems to monitor athlete hydration levels, pushing the boundaries of performance and wellbeing with real-time sweat analysis. Is this the future of athletic training?

A new program aims to tackle soaring health costs by offering employer-sponsored access to popular weight-loss drugs, potentially expanding access while curbing expenses.

Amid ongoing drug shortages, Phlow Corp. is advocating for a stronger domestic pharmaceutical supply chain. CEO Dr. Eric Edwards testified before Congress, highlighting the need for resilience and innovation in American medicine.

A new weight loss supplement promising rapid results is drawing skepticism as questions emerge regarding its clinical validation, company registration, and scientific backing. Is this a breakthrough or buyer beware?

A potential new FDA initiative aims to drastically reduce response times to drug sponsors, but details remain unconfirmed. Is this a sign of a changing regulatory landscape?

A leading materials science company unveils a potential breakthrough in tire technology, offering an alternative to a chemical linked to the deaths of coho salmon and other aquatic life. The innovation faces regulatory hurdles and competition.

European regulators endorse a novel pertussis vaccine, offering a targeted approach to bolster immunity and address waning protection against the highly contagious respiratory illness.

Molecular Designs launches a new multiplex PCR panel designed to accelerate HPV research, offering improved efficiency and accuracy for scientists studying cancer prevention and treatment.

The FDA's approval of POHERDY marks a significant step forward in affordable cancer care, introducing the first biosimilar alternative to PERJETA for HER2-positive breast cancer patients.

A promising higher dose of Biogen’s SMA therapy, Spinraza, hit a snag with the FDA, despite positive trial data. The company navigates a crowded market with rivals innovating gene therapies and oral treatments.

For years, dental health was seen as separate from overall well-being. Now, research reveals a powerful connection – and why your dentist may be key to preventing serious illness.

As CBD gains popularity, a growing need exists for informed patient-doctor discussions. One company is stepping up to bridge the knowledge gap and empower better healthcare conversations.

As personalized health gains traction, Parsley Health’s new Longevity Labs program offers a deeper dive into biomarkers—but how does it stack up against a rapidly growing field of competitors?

A new patient guide from leading organizations seeks to demystify genetic testing for prostate cancer, a rapidly evolving field offering personalized treatment options. But who benefits, and what are the potential drawbacks?

Direct-to-consumer epigenetic testing is booming, promising insights into biological age and health risks. But experts raise questions about accuracy, interpretation, and whether the science truly delivers on its promises.

A new direct-to-consumer epigenetic test aims to map aging at the organ level. We investigate the science, the cost, and the implications for the burgeoning longevity market.